Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Oncology drugs in the crosshairs of pharmaceutical crime.Published in
Lancet Oncol 2018; 19(4):e209-217Publiekssamenvatting
Oncology drugs clearly have become a target for pharmaceutical crime. In 2016, falsified oncology drugs ranked fifth in the most commonly falsified drug category among the reports received by the Pharmaceutical Security Institute. Although the prevalence of illicit oncology drugs in the legal supply chains appears to be small, these drugs are difficult to detect, particularly in clinical practice. Forthcoming countermeasures to detect illicit drugs in high-income countries include compulsory antitampering devices and product verification technology for a risk-based selection of medicines. Health-care professionals must implement these new procedures into their workflow and remain vigilant about those medicines that are not selected. Although countermeasures should firmly tighten supply chain security, there are concerns about how quickly pharmaceutical crime will adapt to these protections. Because patients and health-care professionals have shown a lenient attitude towards purchasing medicines from unreliable sources, measures against the highly accessible illegal medicine supply chain remain necessary. To improve detectability in clinical practice, reporting of ineffectiveness and unusual drug effects as adverse events or adverse drug reactions is essential.PMID
29611529ae974a485f413a2113503eed53cd6c53
10.1016/S1470-2045(18)30101-3
Scopus Count
Collections
Related articles
- [Counterfeit and Falsified Drugs: an Overview].
- Authors: Taverriti-Fortier C, Pape E, Scala-Bertola J, Tréchot P, Maincent P, Gibaja V, Gambier N
- Issue date: 2015 Sep-Oct
- Fighting trafficking of falsified and substandard medicinal products in Russia.
- Authors: Fayzrakhmanov NF
- Issue date: 2015
- [securPharm e. V. - a protective shield against falsified medicines].
- Authors: Bergen M, Hoferichter R
- Issue date: 2017 Nov
- [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
- Authors: Wittstock M, Paeschke N
- Issue date: 2017 Nov
- Legal aspects of counteracting the trafficking of falsified medicines in the european union.
- Authors: Pashkov V, Soloviov A, Olefir A
- Issue date: 2017